Patient and disease characteristics at baseline
| Characteristic . | Patients (n = 68) . |
|---|---|
| Sex, n (%) | |
| Male | 35 (51) |
| Female | 33 (49) |
| Median age, years (range) | 72 (66-86) |
| ECOG performance status, n (%) | |
| 0 | 25 (37) |
| 1 | 28 (41) |
| 2 | 15 (22) |
| ISS stage, n (%) | |
| 1 | 23 (34) |
| 2 | 21 (31) |
| 3 | 24 (35) |
| Median creatinine level, μM/L (range) | 88 (43-250) |
| Patients with creatinine clearance <60 mL/min (%) | 7 (10) |
| Median calcium level (mM/L) (range) | 2.34 (2.01-2.99) |
| Patients with calcium level >2.75 mM/L (%) | 4 (6) |
| Median hemoglobin level (g/dL) (range) | 10.8 (7.4-14.3) |
| Patients with hemoglobin level <10 g/dL (%) | 19 (27.9) |
| Cytogenetics (FISH), n (missing) | 59 (9 missing data) |
| t(4;14), n (%) | 5 (8) |
| del17p, n (%) | 6 (10) |
| no t(4;14); no del17p, n (%) | 48 (82) |
| Characteristic . | Patients (n = 68) . |
|---|---|
| Sex, n (%) | |
| Male | 35 (51) |
| Female | 33 (49) |
| Median age, years (range) | 72 (66-86) |
| ECOG performance status, n (%) | |
| 0 | 25 (37) |
| 1 | 28 (41) |
| 2 | 15 (22) |
| ISS stage, n (%) | |
| 1 | 23 (34) |
| 2 | 21 (31) |
| 3 | 24 (35) |
| Median creatinine level, μM/L (range) | 88 (43-250) |
| Patients with creatinine clearance <60 mL/min (%) | 7 (10) |
| Median calcium level (mM/L) (range) | 2.34 (2.01-2.99) |
| Patients with calcium level >2.75 mM/L (%) | 4 (6) |
| Median hemoglobin level (g/dL) (range) | 10.8 (7.4-14.3) |
| Patients with hemoglobin level <10 g/dL (%) | 19 (27.9) |
| Cytogenetics (FISH), n (missing) | 59 (9 missing data) |
| t(4;14), n (%) | 5 (8) |
| del17p, n (%) | 6 (10) |
| no t(4;14); no del17p, n (%) | 48 (82) |
ECOG, Eastern Cooperative Oncology Group; FISH, fluorescence in situ hybridization; ISS, International Staging System.